President-elect Donald Trump’s HHS appointees represent a broad spectrum of healthcare perspectives and are poised to significantly influence public health, pharmaceuticals and health systems.
With a $1.8 trillion budget in 2024, the department’s leadership will have the authority to direct policy, allocate resources, and oversee pivotal agencies — including the CDC, FDA, CMS and NIH — affecting the lives of hundreds of millions of Americans
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
